24 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Aarey Drugs & Pharmaceuticals Ltd.

BSE

  • 101.90 2.90 (2.93%)
  • Vol: 97747
  • BSE Code: 524412
  • PREV. CLOSE
    99.00
  • OPEN PRICE
    99.90
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    101.65(500)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Aarey Drugs & Pharmaceuticals Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
02-Mar-201710-Mar-2017 Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is to be held on March 10, 2017, inter alia, to discuss and consider transacting the following business: 1. The Company has received a proposal to infuse funds including take over of Forel Labs Pvt. Ltd., a Company which has production facility at Visakhapatnam, Andhra Pradesh. a. The business of Forel Labs. Pvt. Ltd. is complementary to the products and production lines of Aarey Drugs & Pharmaceuticals Ltd., hence the said proposal shall be fruitful to the Company. The factory of Forel Labs Pvt. Ltd. is situated on 45000 sq. mtrs. of land and is a state of art production unit and USA FDA compliant. b. The Board will discuss the proposal to discuss the plan with existing bankers and creditors of Forel Labs Pvt. Ltd. 2. To discuss the status of the on -going expansion at the plant of the Company.
10-Jan-201718-Jan-2017 Quarterly Results
12-Dec-201619-Dec-2016 Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is to be held on December 19, 2016, to transact the following business: 1. To review current business and raising funds from the Banks. 2. To consider the issue of Equity shares and /or warrants on preferential basis to the Promoters/ Non-Promoters of the Company.
05-Oct-201614-Oct-2016 Quarterly Results
26-Aug-201630-Aug-2016 Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is to be held on August 30, 2016, inter alia, to transact the following business: 1. To approve the Draft Notice of the 26th Annual General Meeting of the Members of the Company to be held on September 30, 2016. 2. To approve the Book Closure. 3. To approve the appointment of Scrutinizer to oversee the E-voting process of the Company at the 26th Annual General Meeting.
01-Aug-201605-Aug-2016 Aarey Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 05, 2016, inter alia, to transact the following business; - Pursuant to the Members approval dated June 08, 2016 and In-principle Approval received from BSE on July 22, 2016, to Allot Equity shares/warrants pursuant to the Preferential Allotment basis.
14-Jul-201618-Jul-2016 Unaudited Financial Results
16-May-201630-May-2016 Audited Results
11-May-201612-May-2016 Aarey Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 12, 2016, to transact the following business: - To approve the draft Notice for convening Extra Ordinary General Meeting to be held on June 08, 2016.
25-Apr-201604-May-2016 Aarey Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 04, 2016, to consider the following: 1. To review the expansion of manufacturing facilities of the Company. 2. To review new tie up to add product line. 3. To review current business and raising funds from Banks. 4. To consider the issue of Equity shares / and or warrants on preferential Basis to the Promoters/Non Promoters of the Company. 5. To increase the authorised capital of the Company.
03-Feb-201615-Feb-2016 Quarterly Results
28-Dec-201530-Dec-2015 The Board of Directors of the Company will be held on December 30, 2015 for the purpose of re-appointment of Mr. Mihir R Ghatalia, Managing Director of the Company whose term expires on December 31, 2015.
24-Dec-201530-Dec-2015 The Board of Directors of the Company will be held on December 30, 2015 for the purpose of re-appointment of Mr. Mihir R Ghatalia, Managing Director of the Company whose term expires on December 31, 2015.
28-Oct-201509-Nov-2015 Quarterly Results
29-Jul-201514-Aug-2015 Quarterly Results
20-May-201530-May-2015 Audited Results
30-Jan-201514-Feb-2015 Quarterly Results
29-Oct-201414-Nov-2014 Quarterly Results
04-Aug-201414-Aug-2014 Quarterly Results